TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.110

-7.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (209)	11/24/1999 6:03:00 PM
From: JMarcus	Read Replies (1) of 557

I bought more TGEN today at 1 7/8. If the publicity coming out of the ASH meeting Dec. 4-6 is good for Avigen, the investment community will start looking around for who else, besides Avigen, has a good foothold in AAV. Remember when Entremed's stock we through the roof, every small biotech company with an anti-angiogenesis drug in development saw its stock rise too. The share price of Avigen has already run up so much in anticipation of the news, it is hard to tell how much pop there will be left. Even with a bunch of new buyers, the momentum players who have been bidding up the stock may match the new demand with an ample supply. Stocks like ARIA and TGEN, which have not moved nearly so much, might see bigger pops that Avigen will. Caveat: the ASH news could be underwhelming. From the abstract posted by Avigen, it looks like the dosage of the patients being reported on may have been too small to produce a therapeutic effect. Much may depend upon how well Avigen pitches the news. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next